MegaPro Biomedical Co., Ltd ^6827.TWO

Finances

	2024	2023	2022	2021	2020	2019
Revenue	14.000 K ^{-22.22 %}	18.000 K	0.000	0.000 ^{-100.00 %}	7.429 M	0.000
Net income	-164.041 M ^{-28.61 %}	-127.548 M ^{-14.16 %}	-111.725 M ^{-25.32 %}	-89.151 M ^{40.11 %}	-148.863 M ^{14.81 %}	-174.740 M
Income before tax	-164.041 M ^{-28.61 %}	-127.552 M ^{-14.61 %}	-111.289 M ^{-24.83 %}	-89.151 M ^{40.11 %}	-148.863 M	0.000
Income before tax ratio	-11 717.21 ^{-65.35 %}	-7 086.22	0.00	0.00 ^{100.00 %}	-20.04	0.00
EBITDA	-146.385 M ^{-32.67 %}	-110.338 M ^{-13.33 %}	-97.359 M ^{-19.29 %}	-81.613 M ^{43.05 %}	-143.311 M ^{19.64 %}	-178.336 M
Net income ratio	-11 717.21 ^{-65.36 %}	-7 086.00	0.00	0.00 ^{100.00 %}	-20.04	0.00
Ratio EBITDA	-10 456.07 ^{-70.58 %}	-6 129.89	0.00	0.00 ^{100.00 %}	-19.29	0.00
Gross profit ratio	-1 228.07 ^{-33.16 %}	-922.28	0.00	0.00 ^{-100.00 %}	1.00	0.00
Weighted average shs out dil	61.209 M ^{18.02 %}	51.863 M ^{-6.38 %}	55.396 M ^{2.44 %}	54.075 M ^{5.49 %}	51.261 M ^{5.11 %}	48.768 M
Weighted average shs out	61.298 M ^{18.19 %}	51.863 M ^{-6.38 %}	55.396 M ^{2.44 %}	54.075 M ^{5.49 %}	51.261 M ^{5.11 %}	48.768 M
EPS diluted	-2.68 ^{-16.52 %}	-2.30 ^{-13.86 %}	-2.02 ^{-22.42 %}	-1.65 ^{43.10 %}	-2.90 ^{18.77 %}	-3.57
Earnings per share	-2.68 ^{-8.94 %}	-2.46 ^{-21.78 %}	-2.02 ^{-22.42 %}	-1.65 ^{43.10 %}	-2.90 ^{18.77 %}	-3.57
Gross profit	-17.193 M ^{-3.57 %}	-16.601 M ^{-22.44 %}	-13.559 M ^{-79.88 %}	-7.538 M ^{-201.47 %}	7.429 M	0.000
Income tax expense	2.000 K ^{150.00 %}	-4.000 K ^{-100.92 %}	436.000 K	0.000	0.000	0.000
Cost of revenue	17.207 M ^{3.54 %}	16.619 M ^{22.57 %}	13.559 M ^{79.88 %}	7.538 M	0.000	0.000
General and administrative expenses	23.295 M ^{-5.11 %}	24.550 M ^{17.87 %}	20.828 M ^{35.12 %}	15.414 M ^{58.50 %}	9.725 M	0.000
Selling and marketing expenses	0.000	0.000	0.000	0.000	0.000	0.000
Other expenses	-17.207 M ^{-3.54 %}	-16.619 M ^{-22.57 %}	-13.559 M ^{-79.88 %}	-7.538 M	0.000 ^{100.00 %}	-178.336 M
Operating expenses	163.000 M ^{31.57 %}	123.886 M ^{14.51 %}	108.187 M ^{15.79 %}	93.437 M ^{-40.39 %}	156.758 M ^{187.90 %}	-178.336 M
Cost and expenses	180.207 M ^{28.26 %}	140.505 M ^{15.41 %}	121.746 M ^{20.57 %}	100.975 M ^{-35.59 %}	156.758 M ^{187.90 %}	-178.336 M
Research and development expenses	156.912 M ^{35.32 %}	115.955 M ^{14.90 %}	100.918 M ^{17.95 %}	85.561 M ^{-41.81 %}	147.033 M	0.000
Selling general and administrative expenses	23.295 M ^{-5.11 %}	24.550 M ^{17.87 %}	20.828 M ^{35.12 %}	15.414 M ^{58.50 %}	9.725 M	0.000
Interest income	5.552 M ^{8.93 %}	5.097 M ^{96.64 %}	2.592 M ^{133.72 %}	1.109 M ^{-52.18 %}	2.319 M	0.000
Interest expense	451.000 K ^{52.88 %}	295.000 K ^{-20.49 %}	371.000 K	0.000	0.000	0.000
Depreciation and amortization	17.207 M ^{3.54 %}	16.619 M ^{22.57 %}	13.559 M ^{79.88 %}	7.538 M ^{25.26 %}	6.018 M	0.000
Operating income	-180.193 M ^{-28.26 %}	-140.487 M ^{-15.39 %}	-121.746 M ^{-20.57 %}	-100.975 M ^{32.38 %}	-149.329 M ^{16.27 %}	-178.336 M
Operating income ratio	-12 870.93 ^{-64.91 %}	-7 804.83	0.00	0.00 ^{100.00 %}	-20.10	0.00
Total other income expenses net	16.152 M ^{24.87 %}	12.935 M ^{23.70 %}	10.457 M ^{-11.56 %}	11.824 M ^{2 437.34 %}	466.000 K	0.000
	2024	2023	2022	2021	2020	2019

	2024	2023	2022	2021	2020	2019
Net debt	-82.022 M ^{31.04 %}	-118.938 M ^{10.77 %}	-133.296 M ^{13.58 %}	-154.243 M ^{-62.01 %}	-95.203 M	0.000
Total investments	59.366 M ^{227.50 %}	18.127 M ^{-84.00 %}	113.324 M ^{-38.41 %}	184.000 M	0.000	0.000
Total debt	5.654 M ^{-32.03 %}	8.318 M ^{-23.89 %}	10.929 M ^{-18.82 %}	13.463 M	0.000	0.000
Accumulated other comprehensive income loss	0.000 ^{-100.00 %}	85.367 M ^{4 883.48 %}	1.713 M ^{109.25 %}	-18.522 M	0.000	0.000
Retained earnings	-555.053 M ^{-41.94 %}	-391.035 M ^{-48.41 %}	-263.487 M ^{19.36 %}	-326.762 M ^{-37.52 %}	-237.611 M	0.000
Common stock	647.209 M ^{1.12 %}	640.052 M ^{11.13 %}	575.959 M ^{0.00 %}	575.959 M ^{19.01 %}	483.959 M	0.000
Total equity	204.351 M ^{-24.05 %}	269.073 M ^{-14.40 %}	314.347 M ^{-22.54 %}	405.837 M ^{64.73 %}	246.366 M	0.000
Other non current liabilities	332.000 K ^{3.11 %}	322.000 K ^{-92.53 %}	4.312 M ^{3.21 %}	4.178 M ^{0.00 %}	4.178 M ^{2 247.19 %}	178.000 K
Long term debt	2.856 M ^{-49.25 %}	5.628 M ^{-32.34 %}	8.318 M ^{-23.89 %}	10.929 M	0.000	0.000
Total non current liabilities	3.188 M ^{-46.42 %}	5.950 M ^{-52.89 %}	12.630 M ^{-16.40 %}	15.107 M ^{261.58 %}	4.178 M	0.000
Other current liabilities	13.978 M ^{-1.41 %}	14.178 M ^{35.25 %}	10.483 M ^{59.51 %}	6.572 M ^{-54.98 %}	14.597 M	0.000
Deferred revenue	0.000	0.000	0.000	0.000	0.000	0.000
Short term debt	2.798 M ^{-47.99 %}	5.380 M ^{3.03 %}	5.222 M ^{2.61 %}	5.089 M	0.000	0.000
Total current liabilities	16.776 M ^{-14.22 %}	19.558 M ^{24.53 %}	15.705 M ^{34.68 %}	11.661 M ^{-20.11 %}	14.597 M	0.000
Total liabilities	19.964 M ^{-21.73 %}	25.508 M ^{-9.98 %}	28.335 M ^{5.85 %}	26.768 M ^{42.57 %}	18.775 M	0.000
Other non current assets	17.851 M ^{-4.61 %}	18.714 M ^{437.45 %}	3.482 M ^{-81.30 %}	18.621 M ^{381.16 %}	3.870 M	0.000
Long term investments	0.000 ^{-100.00 %}	18.127 M	0.000	0.000	0.000	0.000
Intangible assets	9.307 M ^{-35.07 %}	14.333 M ^{-27.16 %}	19.678 M ^{-21.51 %}	25.071 M ^{-17.24 %}	30.294 M	0.000
GoodWill	0.000	0.000	0.000	0.000	0.000	0.000
Goodwill and intangible assets	9.307 M ^{-35.07 %}	14.333 M ^{-27.16 %}	19.678 M ^{-21.51 %}	25.071 M ^{-17.24 %}	30.294 M	0.000
Property plant equipment net	22.588 M ^{-31.00 %}	32.735 M ^{-19.15 %}	40.491 M ^{115.89 %}	18.755 M ^{373.49 %}	3.961 M	0.000
Total non current assets	49.746 M ^{-40.71 %}	83.909 M ^{31.83 %}	63.651 M ^{1.22 %}	62.883 M ^{63.07 %}	38.561 M ^{8 744.27 %}	436.000 K
Other current assets	85.401 M ^{315.78 %}	20.540 M ^{-84.51 %}	132.636 M ^{643.64 %}	17.836 M ^{-86.42 %}	131.310 M ^{18 939.31 %}	-697.000 K
Short term investments	59.366 M	0.000 ^{-100.00 %}	113.324 M ^{-38.41 %}	184.000 M	0.000	0.000
cash and cash equivalents	87.676 M ^{-31.10 %}	127.256 M ^{-11.77 %}	144.225 M ^{-14.00 %}	167.706 M ^{76.16 %}	95.203 M	0.000
Cash and short term investments	87.676 M ^{-53.33 %}	187.878 M ^{30.27 %}	144.225 M ^{-58.99 %}	351.706 M ^{269.43 %}	95.203 M	0.000
Total current assets	174.569 M ^{-17.14 %}	210.672 M ^{-24.50 %}	279.031 M ^{-24.53 %}	369.722 M ^{63.18 %}	226.580 M	0.000
Inventory	0.000	0.000	0.000	0.000	0.000	0.000
Net receivables	1.492 M ^{-33.81 %}	2.254 M ^{3.87 %}	2.170 M ^{1 105.56 %}	180.000 K ^{168.66 %}	67.000 K ^{-90.39 %}	697.000 K
Tax assets	0.000	0.000	0.000 ^{-100.00 %}	436.000 K ^{0.00 %}	436.000 K ^{0.00 %}	436.000 K
Other assets	0.000	0.000	0.000	0.000	0.000	0.000
Account payables	0.000	0.000	0.000	0.000	0.000	0.000
Tax payables	0.000	0.000	0.000	0.000	0.000	0.000
Deferred revenue non current	0.000	0.000	0.000	0.000	0.000	0.000
Minority interest	0.000	0.000	0.000	0.000	0.000	0.000
Capital lease obligations	5.628 M ^{-32.34 %}	8.318 M ^{-23.89 %}	10.929 M ^{-18.82 %}	13.463 M	0.000	0.000
Preferred stock	0.000	0.000	0.000	0.000	0.000	0.000
Other total stockholders equity	112.195 M ^{271.79 %}	-65.311 M ^{-40 415.43 %}	162.000 K ^{-99.91 %}	175.162 M ^{973 022.22 %}	18.000 K ^{-99.98 %}	85.569 M
Deferred tax liabilities non current	0.000	0.000	0.000	0.000	0.000	0.000
Other liabilities	0.000	0.000	0.000	0.000	0.000	0.000
Total assets	224.315 M ^{-23.85 %}	294.581 M ^{-14.04 %}	342.682 M ^{-20.79 %}	432.605 M ^{63.16 %}	265.141 M	0.000
	2024	2023	2022	2021	2020	2019

	2024	2023	2022	2021	2020	2019
Deferred income tax	0.000	0.000	0.000	0.000	0.000	0.000
Stock based compensation	15.873 M ^{0.97 %}	15.720 M ^{-22.22 %}	20.212 M ^{458.03 %}	3.622 M	0.000	0.000
Change in working capital	-7.546 M ^{-2 632.21 %}	298.000 K ^{-57.12 %}	695.000 K ^{107.39 %}	-9.409 M ^{22.67 %}	-12.168 M ^{-243.15 %}	-3.546 M
Accounts receivables	39.000 K ^{-97.76 %}	1.743 M ^{197.76 %}	-1.783 M ^{-12 835.71 %}	14.000 K ^{380.00 %}	-5.000 K ^{-104.85 %}	103.000 K
Inventory	0.000	0.000	0.000	0.000	0.000	0.000
Accounts payables	0.000	0.000	0.000	0.000	0.000	0.000
Other working capital	-7.585 M ^{-424.91 %}	-1.445 M ^{-158.31 %}	2.478 M ^{126.30 %}	-9.423 M ^{22.53 %}	-12.163 M ^{-233.32 %}	-3.649 M
Other non cash items	-5.659 M ^{-18.29 %}	-4.784 M ^{19.95 %}	-5.976 M ^{-352.15 %}	2.370 M ^{284.44 %}	-1.285 M ^{-176.17 %}	1.687 M
Net cash provided by operating activities	-144.166 M ^{-44.60 %}	-99.699 M ^{-20.41 %}	-82.799 M ^{2.62 %}	-85.030 M ^{45.60 %}	-156.298 M ^{8.47 %}	-170.758 M
Investments in property plant and equipment	-1.171 M ^{73.31 %}	-4.387 M ^{67.51 %}	-13.501 M ^{24.63 %}	-17.914 M ^{-138.28 %}	-7.518 M ^{-680.69 %}	-963.000 K
Acquisitions net	18.990 M ^{94 850.00 %}	20.000 K	0.000 ^{-100.00 %}	10.000 K	0.000	0.000
Purchases of investments	0.000	0.000 ^{-100.00 %}	70.672 M ^{205.64 %}	-66.900 M ^{-136.19 %}	184.854 M ^{150.76 %}	73.717 M
Sales maturities of investments	5.990 M ^{-89.08 %}	54.865 M ^{-22.37 %}	70.672 M ^{205.64 %}	-66.900 M ^{-136.19 %}	184.854 M ^{150.76 %}	73.717 M
Other investing activites	0.000 ^{100.00 %}	-31.714 M ^{55.61 %}	-71.437 M ^{-207.56 %}	66.417 M ^{135.93 %}	-184.854 M ^{-150.76 %}	-73.717 M
Net cash used for investing activites	23.809 M ^{26.75 %}	18.784 M ^{-66.70 %}	56.406 M ^{166.14 %}	-85.287 M ^{-148.09 %}	177.336 M ^{143.75 %}	72.754 M
Debt repayment	26.000 K	0.000	0.000	0.000	0.000	0.000
Common stock issued	84.527 M ^{29.10 %}	65.473 M	0.000 ^{-100.00 %}	245.000 M	0.000 ^{-100.00 %}	83.200 M
Common stock repurchased	0.000	0.000	0.000	0.000	0.000	0.000
Dividends paid	0.000	0.000	0.000	0.000	0.000	0.000
Other financing activites	-2.716 M ^{-4.02 %}	-2.611 M ^{-3.98 %}	-2.511 M	0.000	0.000	0.000
Net cash used provided by financing activities	81.837 M ^{30.19 %}	62.862 M ^{2 603.46 %}	-2.511 M ^{-101.02 %}	245.000 M	0.000 ^{-100.00 %}	83.200 M
Effect of forex changes on cash	-1.060 M ^{-197.79 %}	1.084 M ^{-80.01 %}	5.423 M ^{348.76 %}	-2.180 M ^{-228.69 %}	1.694 M ^{3 421.57 %}	-51.000 K
Net change in cash	-39.580 M ^{-133.25 %}	-16.969 M ^{27.73 %}	-23.481 M ^{-132.39 %}	72.503 M ^{218.95 %}	22.732 M ^{253.03 %}	-14.855 M
Cash at beginning of period	127.256 M ^{-11.77 %}	144.225 M ^{-14.00 %}	167.706 M ^{76.16 %}	95.203 M ^{31.37 %}	72.471 M ^{-17.01 %}	87.326 M
Cash at end of period	87.676 M ^{-31.10 %}	127.256 M ^{-11.77 %}	144.225 M ^{-14.00 %}	167.706 M ^{76.16 %}	95.203 M ^{31.37 %}	72.471 M
Operating cash flow	-144.166 M ^{-44.60 %}	-99.699 M ^{-20.41 %}	-82.799 M ^{2.62 %}	-85.030 M ^{45.60 %}	-156.298 M ^{8.47 %}	-170.758 M
Capital expenditure	-1.171 M ^{73.31 %}	-4.387 M ^{67.51 %}	-13.501 M ^{24.63 %}	-17.914 M ^{-138.28 %}	-7.518 M ^{-680.69 %}	-963.000 K
Free CashFlow	-145.337 M ^{-39.63 %}	-104.086 M ^{-8.09 %}	-96.300 M ^{6.45 %}	-102.944 M ^{37.16 %}	-163.816 M ^{4.60 %}	-171.721 M
	2024	2023	2022	2021	2020	2019

	2025-06-30	2024-12-31	2024-06-30	2023-12-31	2023-06-30	2022-12-31
Revenue	0.000	0.000 ^{-100.00 %}	14.000 K ^{-22.22 %}	18.000 K	0.000	0.000
Net income	-66.936 M ^{22.89 %}	-86.807 M ^{-12.39 %}	-77.234 M ^{-18.69 %}	-65.072 M ^{-4.16 %}	-62.476 M ^{-26.36 %}	-49.441 M
Income before tax	-66.936 M ^{22.89 %}	-86.807 M ^{-12.39 %}	-77.236 M ^{-18.81 %}	-65.008 M ^{-4.44 %}	-62.244 M ^{-27.02 %}	-49.005 M
Income before tax ratio	0.00	0.00 ^{100.00 %}	-5 516.86 ^{-52.76 %}	-3 611.56	0.00	0.00
EBITDA	-58.394 M ^{25.25 %}	-78.123 M ^{-14.45 %}	-68.262 M ^{-20.77 %}	-56.524 M ^{-5.04 %}	-53.814 M ^{-31.19 %}	-41.021 M
Net income ratio	0.00	0.00 ^{100.00 %}	-5 516.71 ^{-52.60 %}	-3 615.11	0.00	0.00
Ratio EBITDA	0.00	0.00 ^{100.00 %}	-4 875.86 ^{-55.27 %}	-3 140.22	0.00	0.00
Gross profit ratio	0.00	0.00 ^{100.00 %}	-614.93 ^{-32.91 %}	-462.67	0.00	0.00
Weighted average shs out dil	67.306 M ^{3.99 %}	64.721 M ^{8.44 %}	59.682 M ^{-2.99 %}	61.520 M ^{3.97 %}	59.170 M ^{-3.82 %}	61.520 M
Weighted average shs out	67.306 M ^{3.99 %}	64.721 M ^{8.44 %}	59.682 M ^{-2.99 %}	61.520 M ^{3.97 %}	59.170 M ^{-3.82 %}	61.520 M
EPS diluted	-0.99 ^{26.12 %}	-1.34 ^{-3.88 %}	-1.29 ^{-21.70 %}	-1.06 ^{0.00 %}	-1.06 ^{-32.50 %}	-0.80
Earnings per share	-0.99 ^{26.12 %}	-1.34 ^{-3.88 %}	-1.29 ^{-21.70 %}	-1.06 ^{0.00 %}	-1.06 ^{-32.50 %}	-0.80
Gross profit	-8.465 M ^{1.39 %}	-8.584 M ^{0.29 %}	-8.609 M ^{-3.37 %}	-8.328 M ^{-0.66 %}	-8.273 M ^{-5.96 %}	-7.808 M
Income tax expense	0.000	0.000	0.000 ^{100.00 %}	-4.000 K	0.000 ^{-100.00 %}	436.000 K
Cost of revenue	8.465 M ^{-1.39 %}	8.584 M ^{-0.45 %}	8.623 M ^{3.32 %}	8.346 M ^{0.88 %}	8.273 M ^{5.96 %}	7.808 M
General and administrative expenses	0.000	0.000	0.000	0.000	0.000	0.000
Selling and marketing expenses	0.000	0.000	0.000	0.000	0.000	0.000
Other expenses	0.000	0.000	0.000	0.000	0.000 ^{-100.00 %}	7.640 M
Operating expenses	55.299 M ^{-33.65 %}	83.346 M ^{4.64 %}	79.654 M ^{18.24 %}	67.369 M ^{19.20 %}	56.517 M ^{24.02 %}	45.571 M
Cost and expenses	63.764 M ^{-30.64 %}	91.930 M ^{4.14 %}	88.277 M ^{16.59 %}	75.715 M ^{16.86 %}	64.790 M ^{21.38 %}	53.379 M
Research and development expenses	54.796 M ^{-33.67 %}	82.614 M ^{11.19 %}	74.298 M ^{16.65 %}	63.691 M ^{21.86 %}	52.264 M ^{10.97 %}	47.099 M
Selling general and administrative expenses	503.000 K ^{-31.28 %}	732.000 K ^{-86.33 %}	5.356 M ^{45.62 %}	3.678 M ^{-13.52 %}	4.253 M ^{-30.42 %}	6.112 M
Interest income	1.557 M ^{-49.56 %}	3.087 M ^{25.23 %}	2.465 M ^{2.79 %}	2.398 M ^{-11.15 %}	2.699 M ^{51.46 %}	1.782 M
Interest expense	77.000 K ^{-23.00 %}	100.000 K ^{-71.51 %}	351.000 K ^{154.35 %}	138.000 K ^{-12.10 %}	157.000 K ^{-10.80 %}	176.000 K
Depreciation and amortization	8.465 M ^{-1.39 %}	8.584 M ^{-0.45 %}	8.623 M ^{3.32 %}	8.346 M ^{0.88 %}	8.273 M ^{5.96 %}	7.808 M
Operating income	-63.764 M ^{30.64 %}	-91.930 M ^{-4.15 %}	-88.263 M ^{-16.60 %}	-75.697 M ^{-16.83 %}	-64.790 M ^{-21.38 %}	-53.379 M
Operating income ratio	0.00	0.00 ^{100.00 %}	-6 304.50 ^{-49.91 %}	-4 205.39	0.00	0.00
Total other income expenses net	-3.172 M ^{-161.92 %}	5.123 M ^{-53.54 %}	11.027 M ^{3.16 %}	10.689 M ^{319.84 %}	2.546 M ^{-41.79 %}	4.374 M
	2025-06-30	2024-12-31	2024-06-30	2023-12-31	2023-06-30	2022-12-31

	2025-06-30	2024-12-31	2024-06-30	2023-12-31	2023-06-30	2022-12-31
Net debt	-58.245 M ^{28.99 %}	-82.022 M ^{53.26 %}	-175.492 M ^{-47.55 %}	-118.938 M ^{-326.88 %}	-27.862 M ^{79.10 %}	-133.296 M
Total investments	30.000 M ^{-49.47 %}	59.366 M ^{48.42 %}	40.000 M ^{120.67 %}	18.127 M ^{5.92 %}	17.114 M	0.000
Total debt	4.273 M ^{-24.43 %}	5.654 M ^{-20.28 %}	7.092 M ^{-14.74 %}	8.318 M ^{-13.65 %}	9.633 M ^{-11.86 %}	10.929 M
Accumulated other comprehensive income loss	32.533 M ^{-12.15 %}	37.033 M ^{34.19 %}	27.598 M ^{-67.67 %}	85.367 M	0.000	0.000
Retained earnings	-546.989 M ^{1.45 %}	-555.053 M ^{-18.54 %}	-468.246 M ^{-19.75 %}	-391.035 M ^{-19.96 %}	-325.963 M ^{-23.71 %}	-263.487 M
Common stock	647.209 M ^{0.00 %}	647.209 M ^{-0.36 %}	649.579 M ^{1.49 %}	640.052 M ^{11.13 %}	575.959 M ^{0.00 %}	575.959 M
Total equity	132.915 M ^{-34.96 %}	204.351 M ^{-28.07 %}	284.093 M ^{5.58 %}	269.073 M ^{2.49 %}	262.534 M ^{-16.48 %}	314.347 M
Other non current liabilities	336.000 K ^{1.20 %}	332.000 K ^{1.53 %}	327.000 K ^{1.55 %}	322.000 K ^{1.58 %}	317.000 K ^{-92.65 %}	4.312 M
Long term debt	1.439 M ^{-49.61 %}	2.856 M ^{-32.83 %}	4.252 M ^{-24.45 %}	5.628 M ^{-19.40 %}	6.983 M ^{-16.05 %}	8.318 M
Total non current liabilities	1.775 M ^{-44.32 %}	3.188 M ^{-30.38 %}	4.579 M ^{-23.04 %}	5.950 M ^{-18.49 %}	7.300 M ^{-42.20 %}	12.630 M
Other current liabilities	24.839 M ^{77.70 %}	13.978 M ^{-5.99 %}	14.869 M ^{4.87 %}	14.178 M ^{-5.01 %}	14.926 M ^{13.99 %}	13.094 M
Deferred revenue	0.000	0.000	0.000	0.000	0.000	0.000
Short term debt	2.834 M ^{1.29 %}	2.798 M ^{-1.48 %}	2.840 M ^{-47.21 %}	5.380 M ^{103.02 %}	2.650 M ^{1.49 %}	2.611 M
Total current liabilities	27.673 M ^{64.96 %}	16.776 M ^{-5.27 %}	17.709 M ^{-9.45 %}	19.558 M ^{11.28 %}	17.576 M ^{11.91 %}	15.705 M
Total liabilities	29.448 M ^{47.51 %}	19.964 M ^{-10.43 %}	22.288 M ^{-12.62 %}	25.508 M ^{2.54 %}	24.876 M ^{-12.21 %}	28.335 M
Other non current assets	17.851 M ^{0.00 %}	17.851 M ^{0.00 %}	17.851 M ^{0.00 %}	17.851 M ^{-48.95 %}	34.965 M ^{904.16 %}	3.482 M
Long term investments	0.000	0.000	0.000 ^{-100.00 %}	18.127 M	0.000	0.000
Intangible assets	6.794 M ^{-27.00 %}	9.307 M ^{-21.26 %}	11.820 M ^{-17.53 %}	14.333 M ^{664.43 %}	1.875 M ^{-13.59 %}	2.170 M
GoodWill	0.000	0.000	0.000	0.000	0.000	0.000
Goodwill and intangible assets	6.794 M ^{-27.00 %}	9.307 M ^{-21.26 %}	11.820 M ^{-17.53 %}	14.333 M ^{-15.56 %}	16.974 M ^{-13.74 %}	19.678 M
Property plant equipment net	17.492 M ^{-22.56 %}	22.588 M ^{-20.77 %}	28.510 M ^{-15.14 %}	33.598 M ^{-5.71 %}	35.631 M ^{-12.00 %}	40.491 M
Total non current assets	42.137 M ^{-15.30 %}	49.746 M ^{-14.50 %}	58.181 M ^{-30.66 %}	83.909 M ^{-4.18 %}	87.570 M ^{37.58 %}	63.651 M
Other current assets	26.746 M ^{-68.68 %}	85.401 M ^{256.97 %}	23.924 M ^{16.48 %}	20.540 M ^{7.14 %}	19.171 M ^{-85.55 %}	132.636 M
Short term investments	30.000 M ^{-49.47 %}	59.366 M ^{48.42 %}	40.000 M	0.000	0.000	0.000
cash and cash equivalents	62.518 M ^{-28.69 %}	87.676 M ^{-51.98 %}	182.584 M ^{43.48 %}	127.256 M ^{239.39 %}	37.495 M ^{-74.00 %}	144.225 M
Cash and short term investments	92.518 M ^{5.52 %}	87.676 M ^{-60.61 %}	222.584 M ^{18.47 %}	187.878 M ^{401.07 %}	37.495 M ^{-74.00 %}	144.225 M
Total current assets	120.226 M ^{-31.13 %}	174.569 M ^{-29.67 %}	248.200 M ^{17.81 %}	210.672 M ^{5.42 %}	199.840 M ^{-28.38 %}	279.031 M
Inventory	0.000	0.000	0.000	0.000	0.000	0.000
Net receivables	962.000 K ^{-35.52 %}	1.492 M ^{-11.82 %}	1.692 M ^{-24.93 %}	2.254 M ^{20.21 %}	1.875 M ^{-13.59 %}	2.170 M
Tax assets	0.000	0.000	0.000	0.000	0.000	0.000
Other assets	0.000	0.000	0.000	0.000	0.000	0.000
Account payables	0.000	0.000	0.000	0.000	0.000	0.000
Tax payables	0.000	0.000	0.000	0.000	0.000	0.000
Deferred revenue non current	0.000	0.000	0.000	0.000	0.000	0.000
Minority interest	0.000	0.000	0.000	0.000	0.000	0.000
Capital lease obligations	1.439 M ^{-74.43 %}	5.628 M ^{32.36 %}	4.252 M ^{-48.88 %}	8.318 M ^{-13.65 %}	9.633 M ^{-11.86 %}	10.929 M
Preferred stock	0.000	0.000	0.000	0.000	0.000	0.000
Other total stockholders equity	162.000 K ^{-99.86 %}	112.195 M ^{49.27 %}	75.162 M ^{215.08 %}	-65.311 M ^{-620.90 %}	12.538 M ^{568.69 %}	1.875 M
Deferred tax liabilities non current	0.000	0.000	0.000	0.000	0.000	0.000
Other liabilities	0.000	0.000	0.000	0.000	0.000	0.000
Total assets	162.363 M ^{-27.62 %}	224.315 M ^{-26.79 %}	306.381 M ^{4.01 %}	294.581 M ^{2.50 %}	287.410 M ^{-16.13 %}	342.682 M
	2025-06-30	2024-12-31	2024-06-30	2023-12-31	2023-06-30	2022-12-31

	2025-06-30	2024-12-31	2024-06-30	2023-12-31	2023-06-30	2022-12-31
Deferred income tax	0.000	0.000	0.000	0.000	0.000	0.000
Stock based compensation	0.000	0.000	0.000	0.000	0.000	0.000
Change in working capital	8.785 M ^{495.90 %}	-2.219 M ^{58.55 %}	-5.353 M ^{-563.06 %}	1.156 M ^{234.73 %}	-858.000 K ^{-124.83 %}	3.455 M
Accounts receivables	-7.000 K ^{-240.00 %}	5.000 K ^{-85.29 %}	34.000 K ^{-94.04 %}	570.000 K ^{-51.41 %}	1.173 M ^{165.86 %}	-1.781 M
Inventory	0.000	0.000	0.000	0.000	0.000	0.000
Accounts payables	0.000	0.000	0.000	0.000	0.000	0.000
Other working capital	8.792 M ^{495.32 %}	-2.224 M ^{58.72 %}	-5.387 M ^{-1 019.28 %}	586.000 K ^{128.85 %}	-2.031 M ^{-138.79 %}	5.236 M
Other non cash items	707.000 K ^{-90.19 %}	7.210 M ^{140.01 %}	3.004 M ^{-47.10 %}	5.679 M ^{8.11 %}	5.253 M ^{5 300.99 %}	-101.000 K
Net cash provided by operating activities	-48.979 M ^{33.12 %}	-73.232 M ^{-3.20 %}	-70.960 M ^{-42.23 %}	-49.891 M ^{-0.17 %}	-49.808 M ^{-30.12 %}	-38.279 M
Investments in property plant and equipment	-857.000 K ^{-475.17 %}	-149.000 K ^{85.42 %}	-1.022 M ^{72.21 %}	-3.678 M ^{-418.76 %}	-709.000 K ^{83.81 %}	-4.379 M
Acquisitions net	5.000 K	0.000	0.000 ^{-100.00 %}	10.000 K ^{0.00 %}	10.000 K	0.000
Purchases of investments	0.000	0.000	0.000 ^{-100.00 %}	27.654 M ^{161.45 %}	-45.000 M	0.000
Sales maturities of investments	26.062 M ^{262.09 %}	-16.079 M ^{-139.16 %}	41.059 M ^{-25.16 %}	54.865 M	0.000 ^{-100.00 %}	28.172 M
Other investing activites	0.000	0.000	0.000 ^{-100.00 %}	1.000 K ^{100.01 %}	-14.369 M ^{-1 396.77 %}	-960.000 K
Net cash used for investing activites	25.210 M ^{255.35 %}	-16.228 M ^{-140.53 %}	40.037 M ^{-49.23 %}	78.852 M ^{231.27 %}	-60.068 M ^{-363.08 %}	22.833 M
Debt repayment	-6.000 K ^{92.77 %}	-83.000 K ^{-176.15 %}	109.000 K	0.000	0.000	0.000
Common stock issued	0.000	0.000 ^{-100.00 %}	84.527 M ^{29.10 %}	65.473 M	0.000	0.000
Common stock repurchased	0.000	0.000	0.000	0.000	0.000	0.000
Dividends paid	0.000	0.000	0.000	0.000	0.000	0.000
Other financing activites	-1.375 M ^{-1.48 %}	-1.355 M ^{-1.50 %}	-1.335 M ^{-1.52 %}	-1.315 M ^{-1.47 %}	-1.296 M ^{-3.43 %}	-1.253 M
Net cash used provided by financing activities	-1.381 M ^{3.96 %}	-1.438 M ^{-101.73 %}	83.301 M ^{29.84 %}	64.158 M ^{5 050.46 %}	-1.296 M ^{-3.43 %}	-1.253 M
Effect of forex changes on cash	-8.000 K ^{99.80 %}	-4.010 M ^{-235.93 %}	2.950 M ^{187.85 %}	-3.358 M	0.000	0.000
Net change in cash	-25.158 M ^{73.49 %}	-94.908 M ^{-271.54 %}	55.328 M ^{-38.36 %}	89.761 M ^{184.10 %}	-106.730 M ^{-641.39 %}	-14.396 M
Cash at beginning of period	87.676 M ^{-51.98 %}	182.584 M ^{43.48 %}	127.256 M ^{239.39 %}	37.495 M ^{-74.00 %}	144.225 M ^{-9.08 %}	158.621 M
Cash at end of period	62.518 M ^{-28.69 %}	87.676 M ^{-51.98 %}	182.584 M ^{43.48 %}	127.256 M ^{239.39 %}	37.495 M ^{-74.00 %}	144.225 M
Operating cash flow	-48.979 M ^{33.12 %}	-73.232 M ^{-3.20 %}	-70.960 M ^{-42.23 %}	-49.891 M ^{-0.17 %}	-49.808 M ^{-30.12 %}	-38.279 M
Capital expenditure	-857.000 K ^{-475.17 %}	-149.000 K ^{85.42 %}	-1.022 M ^{72.21 %}	-3.678 M ^{-418.76 %}	-709.000 K ^{83.81 %}	-4.379 M
Free CashFlow	-49.836 M ^{32.09 %}	-73.381 M ^{-1.94 %}	-71.982 M ^{-34.37 %}	-53.569 M ^{-6.04 %}	-50.517 M ^{-18.42 %}	-42.658 M
	2025	2024	2024	2023	2023	2022

Date	Form 10K
2024
2023
2022
2021
2020
2019

MegaPro Biomedical Co., Ltd 6827.TWO

Finances

MegaPro Biomedical Co., Ltd ^6827.TWO